IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Randomized Study of Train the Colonoscopy Leaders Course Versus Audit and Feedback on Colonoscopy Quality Indicators
This study has been completed.
Sponsor:
Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology
Collaborators:
Centre of Postgraduate Medical Education
Gloucestershire Hospitals NHS Foundation Trust
University of Oslo
Erasmus Medical Center
Ministry of Science and Higher Education, Poland
Information provided by (Responsible Party):
Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology
ClinicalTrials.gov Identifier:
NCT01667198
First received: August 14, 2012
Last updated: April 15, 2014
Last verified: April 2014
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Professional societies recommend that endoscopists measure their ceacal intubation rate, adenoma detection rate as indicators of the screening colonoscopy quality. However, it is uncertain how to improve adenoma detection rate and reduce inter-endoscopists' variability in the detection of adenomas. The investigators hypothesize that a hands-on-training intervention tailored to the results of environmental assessment and audit on colonoscopy quality indicators results in higher adenoma detection rate improvement than simple audit and feedback. The investigators further hypothesize that by training the leaders of the screening centres, the effect of the intervention will be further disseminated among other endoscopists from the participating centers, and will thus result in additional increase in individual adenoma detection rate.
The primary aim is to compare the impact on adenoma detection rate of two screening colonoscopy improvement programs:
- Tailored training intervention.
- Audit feedback on colonoscopy quality indicators.
| Condition | Intervention |
|---|---|
| Colorectal Cancer | Procedure: Train the leaders course Behavioral: Audit and feedback |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Health Services Research |
| Official Title: | Quality Improvement in Screening Colonoscopy - a Randomized Trial of Tailored Training Intervention Versus Simple Feedback on the Quality Indicators. |
Resource links provided by NLM:
Further study details as provided by Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology:
Primary Outcome Measures:
- Screening centre leader's adenoma detection rate [ Time Frame: till the end of calendar year after the training intervention ]Adenoma detection rate is defined as the proportion of screened subjects in whom at least one adenomatous lesion is identified.
Secondary Outcome Measures:
- Screening center's overall adenoma detection rate [ Time Frame: Till the end of calendar year after the training intervention ]Adenoma detection rate is defined as the proportion of screened subjects in whom at least one adenomatous lesion is identified.
- Screening centre leader's proximal and distal adenoma detection rate [ Time Frame: Till the end of calendar year after the training intervention ]Adenoma detection rate is defined as the proportion of screened subjects in whom at least one adenomatous lesion is identified.
- Screening centre's non-polypoid lesion detection rate [ Time Frame: Till the end of calendar year after the training intervention ]
- Overall screening centre's ceacal intubation rate [ Time Frame: Till the end of calendar year after the training intervention ]Ceacal intubation is defined as the passage of the colonoscope tip to a point proximal to the ileoceacal valve and visualization of the entire ceacum.
- Screening centre leader's withdrawal technique [ Time Frame: Till the end of calendar year after the training intervention ]Withdrawal technique assessed by a trained endoscopy nurse
| Enrollment: | 40 |
| Study Start Date: | July 2012 |
| Study Completion Date: | December 2012 |
| Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Train the leaders course |
Procedure: Train the leaders course
Screening centre leaders randomized to the training intervention group will be invited to take part in a train-the-leaders course. The Train-the-leaders course will consist of three phases: (i) pre-training assessment, (ii) hands-on-training and (iii) post-training evaluation and feedback. The Train-the-leaders course will be run in polish by the team from the Maria Sklodowska-Curie Memorial Cancer Center and Institute on Oncology, Warsaw, which was trained in delivering such intervention by experts from the United Kingdom.
|
| Active Comparator: Audit and feedback |
Behavioral: Audit and feedback
Screening centre leaders randomized to the feedback group will receive (by e-mail and conventional mail) feedback on their individual screening colonoscopy quality indicators (adenoma detection rate and ceacal intubation rate) measured for the 2011 edition of the national screening program. The results will be presented in a league table in order to enable comparison with anonymous results of all endoscopists who performed at least 30 colonoscopies within the screening program. In addition, a link to a webpage containing data on individual and overall colonoscopy quality indicators over the last four years of the screening program will be provided.
|
Eligibility| Ages Eligible for Study: | Child, Adult, Senior |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- screening center leading colonoscopist
- at least 30 screening colonoscopies in the 2011 edition of the screening program
- adenoma detection rate lower than 25%
Exclusion Criteria:
- lack of participation in the 2012 edition of the screening program
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01667198
Please refer to this study by its ClinicalTrials.gov identifier: NCT01667198
Locations
| Poland | |
| The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology | |
| Warsaw, Poland, 02-781 | |
Sponsors and Collaborators
Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology
Centre of Postgraduate Medical Education
Gloucestershire Hospitals NHS Foundation Trust
University of Oslo
Erasmus Medical Center
Ministry of Science and Higher Education, Poland
Investigators
| Principal Investigator: | Michal F. Kaminski, MD, PhD | The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology |
| Study Chair: | Jaroslaw Regula, MD, PhD | The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland |
More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology |
| ClinicalTrials.gov Identifier: | NCT01667198 History of Changes |
| Other Study ID Numbers: |
IP2010016270 |
| Study First Received: | August 14, 2012 |
| Last Updated: | April 15, 2014 |
Additional relevant MeSH terms:
|
Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |
ClinicalTrials.gov processed this record on July 24, 2017